Literature DB >> 20332251

High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.

Maritta Sämpi1, Marja Veneskoski, Olavi Ukkola, Y Antero Kesäniemi, Sohvi Hörkkö.   

Abstract

CONTEXT: Plasma oxidized low-density lipoprotein (OxLDL) is known to be associated with obesity, metabolic syndrome, and diabetes.
OBJECTIVE: The objective of the study was to investigate the association between plasma IgA, IgM, and IgG titers to OxLDL, phosphocholine (PC), and streptococcal cell wall polysaccharide (CWPS) and markers of glucose metabolism, type 2 diabetes, and liver adiposity. SETTING AND PARTICIPANTS: A population-based cohort of middle-aged Finns (n = 1039) participated in the study.
DESIGN: Plasma IgM, IgG, and IgA to copper oxidized LDL (CuOx-LDL) and malondialdehyde-modified low-density lipoprotein (MDA-LDL), PC, and CWPS were determined with chemiluminescent ELISA and liver adiposity with ultrasonography.
RESULTS: IgA autoantibody titers to OxLDL and PC, but not CWPS, were positively associated with fasting blood glucose and plasma insulin levels and inversely with insulin sensitivity index. IgA to OxLDL was significantly higher (P = 0.013 for CuOx-LDL and P = 0.016 for MDA-LDL) and IgG to OxLDL significantly lower (P = 0.036 for CuOx-LDL and P = 0.001 for MDA-LDL) among the subjects with type 2 diabetes compared with subjects with normal or impaired glucose metabolism when adjusted for age, sex, body mass index, smoking, and alcohol consumption. Logistic regression analysis showed that high plasma IgA to OxLDL and low IgG to MDA-LDL were independent risk factors for type 2 diabetes. Plasma IgA titers to OxLDL demonstrated a significant association with liver adiposity (P = 0.012) and gamma-glutamyltransferase levels (P = 0.002).
CONCLUSIONS: Plasma IgA titers to OxLDL were positively and IgG titers negatively associated with markers of glucose metabolism. High plasma IgA and low IgG to OxLDL were independent risk factors for type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332251     DOI: 10.1210/jc.2009-1858

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Impact of Diabetes on the Gut and Salivary IgA Microbiomes.

Authors:  Eric L Brown; Heather T Essigmann; Kristi L Hoffman; Noah W Palm; Sarah M Gunter; Joel M Sederstrom; Joseph F Petrosino; Goo Jun; David Aguilar; William B Perkison; Craig L Hanis; Herbert L DuPont
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.609

2.  Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Authors:  Pauliina Pisto; Merja Santaniemi; Risto Bloigu; Olavi Ukkola; Y Antero Kesäniemi
Journal:  BMJ Open       Date:  2014-03-20       Impact factor: 2.692

3.  Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy.

Authors:  Satu Vavuli; Tuire Salonurmi; Sirpa Loukovaara; Antti E Nissinen; Markku J Savolainen; M Johanna Liinamaa
Journal:  J Diabetes Res       Date:  2016-12-20       Impact factor: 4.011

4.  Qualitative and Quantitative Analysis of B-Cell-Produced Antibodies in Vitreous Humor of Type 2 Diabetic Patients with Diabetic Retinopathy.

Authors:  Baoyi Liu; Yijun Hu; Qiaowei Wu; Yunkao Zeng; Yu Xiao; Xiaomin Zeng; Ying Fang; Liang Zhang; Tao Li; Honghua Yu
Journal:  J Diabetes Res       Date:  2020-06-30       Impact factor: 4.011

5.  Lipoprotein metabolism in nonalcoholic fatty liver disease.

Authors:  Zhenghui Gordon Jiang; Simon C Robson; Zemin Yao
Journal:  J Biomed Res       Date:  2012-12-01

6.  Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.

Authors:  Björn Fagerberg; Ulrica Prahl Gullberg; Ragnar Alm; Jan Nilsson; Gunilla Nordin Fredrikson
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

7.  Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.

Authors:  Daniel R Anderson; Michael J Duryee; Scott W Shurmur; John Y Um; Walter D Bussey; Carlos D Hunter; Robert P Garvin; Harlan R Sayles; Ted R Mikuls; Lynell W Klassen; Geoffrey M Thiele
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.